Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1988-12-13
1990-11-27
Lone, Werren B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
560 16, 562401, 562427, A61K 31195, C07C32349
Patent
active
049736043
ABSTRACT:
This invention relates to several thromboxane A.sub.2 inhibiting 7-[3-.alpha.-[1-[[(phenylamino)-thioxomethyl]hydrazono]ethyl]-bicyclo[2.2. 1]-heptenoic acids, pharmaceutical compositions employing them and methods of their use.
REFERENCES:
patent: 4416896 (1983-11-01), Nakane et al.
patent: 4456617 (1984-06-01), Nakane et al.
patent: 4596823 (1986-06-01), Jones et al.
Armstrong et al., Br. J. Pharmac. (1985), V. 84, pp. 595-607.
Wilson et al, Advances in Pros., Throm. & Leukotriene Res., vol. 14, (1985), pp. 393-425.
Nakane et al, Advances in Pros., Throm. & Leukotriene Res., (1985), vol. 15, p. 291.
Sprague et al, Advances in Pros., Throm. & Leukotriene Res., (1980), vol. 6, pp. 493-496.
Garland Robert B.
Miyano Masateru
Clarke Vera C.
Lone Werren B.
National Research Development Corporation
LandOfFree
Thromboxane A.sub.2 antagonists and pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thromboxane A.sub.2 antagonists and pharmaceutical compositions , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thromboxane A.sub.2 antagonists and pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1032104